Sections
Shows
Events
Natco Pharma launches blood cancer drug priced Rs 5,000-20,000, down 98% from US price
Patent war: FRAND is what the doctor has ordered for drugs as well
Sensex up 100 points as FM promises more reforms, Natco up on licence win
Cipla's brave act: Will cancer treatment go the AIDS way?
India revokes Roche patent; questions high price of drug
The Intellectual Property Appellate Board (IPAB) cited a lack of evidence that the drug was any better than existing treatments and its high price as reasons for the decision.
